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ABSTRACT: NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria is a complicated,
energy-transducing, membrane-bound enzyme that contains 45 different subunits, a non-covalently bound
ﬂavin mononucleotide, and eight iron-sulfur clusters. The mechanisms of NADH oxidation and
intramolecular electron transfer by complex I are gradually being deﬁned, but the mechanism linking
ubiquinone reduction to proton translocation remains unknown. Studies of ubiquinone reduction by isolated
complex I are problematic because the extremely hydrophobic natural substrate, ubiquinone-10, must be
substituted with a relatively hydrophilic analogue (such as ubiquinone-1). Hydrophilic ubiquinones are
reduced by an additional, non-energy-transducing pathway (which is insensitive to inhibitors such as
rotenone and piericidin A). Here, we show that inhibitor-insensitive ubiquinone reduction occurs by a
ping-pong type mechanism, catalyzed by the ﬂavin mononucleotide cofactor in the active site for NADH
oxidation. Moreover, semiquinones produced at the ﬂavin site initiate redox cycling reactions with molecular
oxygen, producing superoxide radicals and hydrogen peroxide. The ubiquinone reactant is regenerated,
so the NADH:Q reaction becomes superstoichiometric. Idebenone, an artiﬁcial ubiquinone showing promise
in the treatment of Friedreich’s Ataxia, reacts at the ﬂavin site. The factors which determine the balance
of reactivity between the two sites of ubiquinone reduction (the energy-transducing site and the ﬂavin
site) and the implications for mechanistic studies of ubiquinone reduction by complex I are discussed.
Finally, the possibility that the ﬂavin site in complex I catalyzes redox cycling reactions with a wide
range of compounds, some of which are important in pharmacology and toxicology, is discussed.
Complex I (NADH:quinone oxidoreductase) is the ﬁrst
enzyme of the electron transport chain in many aerobically
respiring organisms (1, 2). In mitochondria, it couples NADH
oxidation and ubiquinone reduction to the translocation of
four protons across the mitochondrial inner membrane,
contributing to the proton motive force that supports ATP
synthesis and transport processes. Complex I from bovine
mitochondria, a model for the human enzyme, comprises 45
different subunits with a combined mass of almost 1 MDa
(3) and nine redox cofactors: a ﬂavin mononucleotide at the
active site for NADH oxidation and eight iron-sulfur
clusters (4, 5). The cofactors are all bound in the hydrophilic
domain of the L-shaped enzyme, and the structure of the
hydrophilic domain from Thermus thermophilus complex I
has been described previously (6). In general, the mechanism
of the redox reaction comprises NADH oxidation by hydride
transfer to the ﬂavin, followed by reoxidation of the ﬂavin
and transfer of the two electrons, along the chain of
iron-sulfur clusters, to bound quinone. The mechanisms of
quinone reduction and coupled proton translocation remain
unknown.
In most mammalian mitochondria, complex I reduces
ubiquinone-10 (coenzyme Q10 or Q10), comprising the
hydrophilic ubiquinone headgroup and 10 isoprenoid units.
The isoprenoid chain renders Q10 extremely hydrophobic,
conﬁning it to the membrane and excluding any possibility
of it dissociating into the mitochondrial matrix. The extreme
hydrophobicity of Q10 also precludes its use in studies of
the isolated enzyme, since they require a signiﬁcant con-
centration of quinone to be present in predominantly aqueous
solutions. Consequently, relatively hydrophilic quinones are
used in functional studies of complex I, commonly decylu-
biquinone (DQ),
1 ubiquinone-1 (coenzyme Q1,Q 1), and also
ubiquinone-0 (coenzyme Q0,Q 0) (see Figure 1) (7-12).
The site(s) at which quinone is bound and reduced by
complex I remains poorly deﬁned. A possible binding site
for the quinone headgroup has been identiﬁed in the structure
of the hydrophilic domain of complex I from T. thermophilus,
close to cluster N2 and the interface with the membrane
domain, formed by the 49 kDa and PSST subunits (6) (we
use the nomenclature for the subunits of bovine complex I
throughout this work). Site-directed mutations in complex I
from Yarrowia lipolytica support the importance of the same
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Published on Web 02/16/2009region in Q binding and reduction (13). A diverse set of
hydrophobic compounds, including rotenone and piericidin
A, are commonly termed “Q-site inhibitors”, because they
inhibit the NADH:quinone oxidoreductase activity of com-
plex I, but not the reduction of hydrophilic electron acceptors
such as ferricyanide (14, 15). A mutation in the 49 kDa
subunit of Rhodobacter capsulatus conferred resistance to
rotenone and piericidin A (16), and radiolabeling experiments
havelocalizedvariousinhibitorstothePSST(17),ND1(17-19),
and ND5 (20) subunits. The latter studies demonstrate that
subunits which are integral to the membrane are important
for quinone reduction also, perhaps because they are required
to accommodate the isoprenoid chain.
Although the Q-site inhibitors are potent inhibitors of Q10
reduction by complex I, many studies have observed that
relatively hydrophilic ubiquinones are reduced in an “inhibi-
tor-insensitive” reaction also, at a second site, upstream of
the Q10-binding site, which is not linked to proton translo-
cation (see, for example, refs 7, 8, 10, and 21). Here we
refer to the physiological, proton-translocating, inhibitor-
sensitive Q-site as the “hydrophobic site” and the non-proton-
translocating, inhibitor-insensitive site as the “hydrophilic
site”. The rates of reduction at the two sites are inﬂuenced
by the identity and hydrophobicity of the ubiquinone (8-12)
and, in studies of the isolated enzyme, by the presence and
concentration of phospholipids in the assay medium (7). The
location of the hydrophilic Q-site is still debated. Brandt and
co-workers have suggested a “hydrophilic entrance” to the
hydrophobic site, allowing hydrophilic quinones to bypass
the inhibitor block (22), and Tormo and Estornell suggested
a large quinone and inhibitor binding site comprising both
hydrophobic and hydrophilic domains (23). Degli Esposti
and co-workers proposed that the “hydrophilic reaction” is
an incomplete reaction at the hydrophobic site (24) or that
hydrophilic quinones are reduced by a protein-bound semi-
quinone species (10). Alternatively, direct interactions with
the iron-sulfur clusters, particularly N2, have been suggested
(24, 25); they are not excluded by the structure of the
hydrophilic domain of complex I from T. thermophilus (6)
because some of the iron-sulfur clusters are within 14 Å of
the solvent accessible surface. Finally, C ˇe ´nas and co-workers
showed that NADH is a competitive inhibitor of 5,8-dioxy-
1,4-naphthoquinone reduction, which is insensitive to 2 µM
rotenone. They concluded that the naphthoquinone binding
site is distinct from, but close to, the NAD+/NADH and
ferricyanide binding sites (26).
Here, we show that the hydrophilic Q-binding site in
complex I overlaps with the NADH binding site. We describe
how the experimental conditions and the identity and
hydrophobicity of the ubiquinone enhance or suppress its
reaction with the reduced ﬂavin in the site and deﬁne the
molecular mechanism and consequences of the reduction
reaction. The importance of hydrophilic Q-reduction for our
understanding of the mechanisms of ubiquinone reduction
and reactive oxygen species production by complex I is
discussed. The short-chain ubiquinone, idebenone, is included
in our studies because it is in clinical trials for the treatment
of Friedreich’s Ataxia, a neurodegenerative disease (27), and
because it displays a signiﬁcant rate of reaction at the
hydrophilic site in complex I (24, 25). Finally, we describe
how the mechanism of hydrophilic ubiquinone reduction by
the ﬂavin in complex I forms a basis for investigation of the
role of complex I in redox cycling reactions which may be
important in pharmacology and toxicology.
EXPERIMENTAL PROCEDURES
Complex I was isolated from bovine mitochondria as
described previously (28) and quantiﬁed using the Pierce
bicinchoninic acid assay. Subcomplex Iλ was prepared from
complex I as described previously (29), except that the size-
exclusion chromatography step was carried out in 0.03%
dodecyl  -D-maltopyranoside. EPR spectra recorded at 12
K did not detect cluster N2 (30). Bovine heart submitochon-
drial particles (SMPs) were prepared using a method based
on that of Kotlyar and Vinogradov (31). Q0,Q 1, and DQ
were from Sigma, and IDE was from Sequoia Research
Products. All quinone stock solutions were prepared in
ethanol and quantiﬁed using an ε275 of 13.7 mM-1 cm-1 (Q1),
an ε263 of 13.6 mM-1 cm-1 (Q0), an ε270 of 19.2 mM-1 cm-1
(DQ), and an ε275 of 13.6 mM-1 cm-1 (IDE) (11, 32).
Kinetic Measurements. Kinetic measurements were carried
out at 32 °C in 1 mL cuvettes in 20 mM Tris-HCl (pH 7.55)
using an Ocean Optics diode array spectrometer. Complex I
was added to a ﬁnal concentration of ∼15 µg/mL from a
15-20 mg/mL stock solution. When required, asolectin
(Fluka) was added to a ﬁnal concentration of 0.4 mg/mL
from a 10 mg/mL stock solution containing 2% (w/v)
CHAPS {3-[(3-cholamidopropyl)dimethylammonio]-1-pro-
panesulfonate (Anatrace)}. Reactions were initiated by the
addition of quinone, from ethanolic stock solutions. SMPs
were added to a ﬁnal concentration of ∼0.05 mg/mL, and
FIGURE 1: Dependence of the NADH:quinone oxidoreductase
activity of isolated complex I on the presence of phospholipids and
inhibitors for four different ubiquinones. Rates were determined
in the presence (gray bars) and absence (white bars) of 0.4 mg/mL
asolectin, without an inhibitor (-) or with 2.3 µM rotenone (R) or
1 µM piericidin (P). Asterisks indicate 23 µM rotenone was used,
as 2.3 µM did not fully inhibit the reaction of IDE at the
hydrophobic site. Conditions: 100 µMQ ,1 0 0µM NADH, 20 mM
Tris-HCl (pH 7.55), 32 °C. Error bars represent the standard
deviation of ﬁve independent measurements. In the presence of
asolectin, the inhibitor sensitivities were approximately 95% (DQ),
90% (Q1), 50% (Q0), and 60% (IDE).
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(Sigma)] was added as an uncoupler. Rotenone or piericidin
A (Sigma) was added to a ﬁnal concentration of 2.3 or 1
µM, respectively, from ethanolic stock solutions. NADH
oxidation was monitored at 340-380 nm (ε ) 4.81 mM-1
cm-1), and the initial rate obtained using linear regression
over 30 s. Anaerobic assays were performed in a glovebox
(Belle Technology, Portesham, U.K.) with <5 ppm O2.
Data were modeled mechanistically using the method
described by Yakovlev and Hirst (33). In brief, the qualities
of the ﬁts from different parameter combinations was
assessed by calculation of least-squares error (LSQE) values
(the sum of the squares of the differences between calculated
and experimental data points). Wide ranges of possible
parameter combinations were assessed using programs coded
in C, and the LSQE values were minimized to give the best
ﬁt.
NADH:Q stoichiometry measurements were carried out
at 32 °Ci n2 0 0µL wells in a Molecular Devices microtiter
plate reader. Assays were initiated by the addition of NADH
(ﬁnal concentrations of 0, 20, 40, 60, 80, 100, 150, and 200
µM) to solutions containing 50 µM Q, complex I, rotenone,
and asolectin as stated. The amount of NADH remaining in
each well was used to calculate the amount which had been
oxidized at each time point; the NADH oxidized did not
depend signiﬁcantly on its initial concentration.
Amplex Red and cyt c Used To Measure H2O2 and O2
-
Production by Complex I. H2O2 production was assessed
stoichiometrically at 32 °C using the horseradish peroxidase
(HRP)-dependent oxidation of Amplex Red to resoruﬁn
[ε557-620)51.6(2.5mM-1cm-1atpH7.5(Sigma)](34,35).
Typically, assays comprised 20 mM Tris-HCl (pH 7.55), 30
µM NADH (Sigma), 2 units/mL HRP (MP Biomedicals,
Aurora, OH), 10 µM Amplex Red (Invitrogen), and ∼15
µg/mL complex I. The NADH concentration was 30 µMt o
minimizeartifactsfromtheAmplexReddetectionsystem(35,36).
When required, catalase [from bovine liver (Sigma)] was
added to a ﬁnal concentration of 1000 or 10000 units/mL.
Superoxide production was assessed stoichiometrically by
monitoring the reduction of 50 µM cyt c [partially acetylated
equine heart cytochrome c; ε550-541 ) 18.0 ( 0.6 mM-1 cm-1
at pH 7.5 (Sigma)] (35, 37). Typically, assays comprised 20
mM Tris-HCl (pH 7.55), 30 µM NADH (Sigma), and ∼15
µg/mL complex I. When required, superoxide dismutase
(SOD) [Cu-Zn-SOD from bovine erythrocytes (Sigma)] was
added to a ﬁnal concentration of 50 units/mL.
RESULTS
Quinones Are Reduced at Two Distinct Sites in BoVine
Complex I. To investigate the inhibitor-insensitive, non-
physiological pathway of quinone reduction by isolated
bovine complex I, four relatively hydrophilic quinones were
used: decylubiquinone (DQ), coenzyme Q1 (Q1), coenzyme
Q0 (Q0), and idebenone (IDE). Figure 1 shows how the rate
of NADH:ubiquinone oxidoreduction by complex I depends
on the identity of the quinone, on the presence of exogenous
phospholipids, and on the presence of the Q-site inhibitors
rotenone and piericidin A, which inhibit only the reaction at
the physiological, energy-transducing site. When phospho-
lipids are present, DQ and Q1 both react much more rapidly
than Q0 and IDE. In the presence of rotenone or piericidin
A, the rates of all four quinones are decreased, but the relative
degree of inhibition of DQ (∼95%) and Q1 (∼90%) is much
greater than that of Q0 (∼50%) and IDE (∼60%). Previous
studies of complex I from bovine heart mitochondria have
determined similar values for the rotenone sensitivity of Q1
reduction: e95% with Q1 (depending on the phospholipid
concentration) (7) and ∼85% with Q1 at concentrations of
<50 µM( 38). When phospholipids are not present, the rates
of all four quinones are decreased, and again, the effect of
the phospholipids is much greater for DQ and Q1 than for
Q0 and IDE. In the absence of phospholipids, the rates are
less susceptible to inhibition by rotenone and piericidin A.
Figure 1 supports the existence of two sites for the reduction
of quinones by complex I: a hydrophobic site that is activated
by phospholipids and inhibited by rotenone and piericidin
A and a hydrophilic site that is not inhibited by rotenone or
piericidin A. The hydrophobic site is the physiological site
of quinone reduction, at which the redox reaction is coupled
to proton translocation. Physical models which may help in
understanding the effects of phospholipids on the two
reactions are discussed below.
To compare the rates of reaction of the four ubiquinones
at each site, the rates in the presence of phospholipids
(without inhibitor) were compared to the rates in the presence
of inhibitor (without phospholipids). The “double-knockout”
condition was used because it is apparent (see Figure 1, DQ)
that neither the omission of phospholipids nor the addition
of inhibitor is completely effective at abolishing the reaction
at the hydrophobic site. Assuming that the rate observed in
the presence of phospholipids is the sum of the rates at the
hydrophilic and hydrophobic sites then, for DQ, Q1,Q 0, and
IDE, the rates at the hydrophobic site are 3.7, 3.3, 0.19, and
0.15 µmol of NADH min-1 mg-1, respectively, and at the
hydrophilic site they are 0.03, 0.49, 0.18, and 0.49 µmol of
NADH min-1 mg-1, respectively. Importantly, neither the
rates at the hydrophobic site (DQ > Q1 . Q0 > IDE) nor
the rates at the hydrophilic site (DQ < Q0 ≈ IDE < Q1)
correlate in a simple fashion with the hydrophobicity of the
ubiquinone [DQ > IDE > Q1 > Q0, based on their
cyclohexane/water partition coefﬁcients (11, 39)]. Therefore,
they are affected by the solubility of the quinone in the
external phase and perhaps by molecular interactions between
the isoprenoid chains and the two binding sites; these effects
are discussed below.
NADH:Q1 oxidoreduction by bovine heart submitochon-
drial particles (SMPs) conﬁrmed that complex I in the
mitochondrial membrane catalyzes the hydrophilic
ubiquinone reduction reaction also. The rate of NADH:O2
oxidoreduction (using endogenous UQ10 and measuring the
rate of NADH oxidation) was 1.26 µmol min-1 mg-1, and it
was 97.8 ( 0.5% sensitive to both rotenone and piericidin
A. In the presence of antimycin A (to prevent cycling of the
endogenous Q10), the rate of Q1 reduction by the SMPs was
0.54 µmol min-1 mg-1, and in the presence of rotenone or
piericidin A, it was ∼0.07 µmol min-1 mg-1, giving an
inhibitor sensitivity of ∼87%. Previous studies have inves-
tigated the inhibitor sensitivity of a range of ubiquinones
using SMPs or broken mitochondria from bovine hearts also.
Lenaz and co-workers reported rotenone sensitivity values
of 72-77% for Q0,9 5 -96% for Q1, and 99% for DQ (9),
and Degli Esposti and co-workers reported values of 89%
(Q1), 94% (DQ), and 63% (IDE) (24). For Q0 and Q1,
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(from 40 to 63% and from 86 to 90%, respectively) were
reported by Di Virgilio and Azzone, reﬂecting the different
apparent KM values of the two quinone binding sites (8).
Finally, the rate of NADH:O2 oxidoreduction by our SMPs
decreased to 0.28 µmol min-1 mg-1 in 100 µM IDE,
consistent with previous work which classiﬁed IDE as a
complex I inhibitor (24). In fact, IDE is better classiﬁed as
a competitive substrate; it appears to inhibit because it
competes for the active site but then reacts only slowly.
Only the Hydrophilic Reaction Is Exhibited by Subcomplex
Iλ. Figure 2 compares NADH:Q1 oxidoreduction by intact
complex I and subcomplex Iλ. The preparation of subcom-
plex Iλ (4) used here contains the ﬂavin, the NADH binding
site, and all of the iron-sulfur clusters except the terminal
cluster, N2, which is lost when the hydrophilic Iλ domain is
resolved. The loss of cluster N2 and the dissociation of the
hydrophilic arm together preclude the occurrence of the
hydrophobic, physiological quinone reduction reaction in
subcomplex Iλ. Figure 2 compares Q1 reduction by complex
I and subcomplex Iλ in the presence of exogenous phos-
pholipids and in the presence and absence of rotenone. As
expected, Q1 reduction by subcomplex Iλ is independent of
the presence of rotenone. The turnover numbers for Q1
reduction by subcomplex Iλ and complex I inhibited by
rotenone are the same (at all Q1 concentrations). Therefore,
the hydrophilic site of quinone reduction is located “up-
stream” of cluster N2. It is fully conserved in subcomplex
Iλ and acts in a manner independent of the hydrophobic site.
The Hydrophilic Reaction Follows a Ping-Pong Reaction
Mechanism at the FlaVin Site. Figure 3 shows that the
reaction rate for the hydrophilic reaction of Q1,Q 0, and IDE
decreases as the NADH concentration is increased. The
behavior is qualitatively similar to that exhibited by the
transhydrogenase reaction catalyzed by complex I, which
follows ping-pong kinetics (the two reactants bind, react, and
dissociate, one after the other, and both at the ﬂavin site)
(33). Inhibition by NADH has been observed also for the
reactions of 5,8-dioxy-1,4-naphthoquinone (26) and ferri-
cyanide (40). Therefore, to investigate the proposal that
hydrophilic quinone reduction occurs at the ﬂavin site, Figure
3 shows how the rate of NADH:Q oxidoreduction depends
on both the NADH and Q concentrations for Q1,Q 0, and
IDE. In all cases, the rate increases as the Q concentration
is increased, indicating that Q does not compete effectively
with NADH for the oxidized ﬂavin (KOx
Q f ∞). However,
the rate increases, then decreases, as the NADH concentration
is increased, indicating that NADH does compete effectively
with Q for the reduced ﬂavin. The data in Figure 3 suggest
two possible reaction mechanisms, which are not mutually
exclusive (Scheme 1). In the ping-pong mechanism, the
reduced ﬂavin is oxidized by Q in a single two-electron step
to form QH2. In the ping-pong-pong mechanism, the reduced
ﬂavin is oxidized by Q in two one-electron steps to form
two semiquinones (Q•- or QH•). Equations 1 and 2 were
derived from Scheme 1, for the ping-pong and ping-pong-
pong pathways, respectively, by using the steady-state
approximation.
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First, data sets for the dependence of rate on NADH and Q
concentration were ﬁtted for Q1,Q 0, and IDE with eq 1, by
varying each parameter to minimize the sum of the squares
of the errors (the LSQE) between the data points and their
equivalent calculated values. The NADH-dependent param-
eters (KM
NADH, kcat
NADH, and KRed
NADH) were set to the same values
for each Q, starting from the values suggested by the
transhydrogenase reaction (94 µM, 2700 s-1, and 200 µM,
respectively) (33), and the Q-dependent parameters were
allowed to vary freely. Satisfactory ﬁts were obtained in all
cases, but, for the best ﬁts, Q1 required a lower value of
KRed
NADH (70 µM) than Q0 and IDE (300 µM) (see Table 1).
Allowing KM
NADH and kcat
NADH to vary did not provide a common
best-ﬁt value for KRed
NADH. Second, an equivalent analysis was
carried out with eq 2. If KSemi
NADH ) KRed
NADH, KM
SQ ) KM2
SQ, and
kcat
SQ ) kcat2
SQ , the ﬁts using the transhydrogenase parameters
were identical to those described above (see Table 1).
However, if KRed
NADH ) 300 µM and KSemi
NADH ) 70 µM
(consistent with tighter NADH binding when the ﬂavin is
more oxidized), and if kcat1
SQ and kcat2
SQ are allowed to differ,
good ﬁts could be derived using the same NADH parameters
for each Q species. Indeed, differences in kcat1
SQ and kcat2
SQ are
expected to result from the differing reactivity of the one-
and two-electron reduced states of the ﬂavin (or of the
enzyme, if the electron from the semiﬂavin is redistributed
to the clusters). In summary, the data shown in Figure 3
provide strong evidence that both substrates (NADH and Q)
are reacting at the same hydrophilic site in complex I. The
data can be explained by mechanisms in which Q is reduced
by either one or two electrons; in fact, it is likely that the
reactions proceed by both pathways, with the relative
contributions of the two varying between the Q species.
FIGURE 2: Complex I inhibited by rotenone catalyzes the reduction
of Q1 at the same rate as subcomplex Iλ. Catalysis by complex I
(O) is signiﬁcantly retarded in the presence of rotenone (b). The
rates of catalysis by subcomplex Iλ in both the presence (2) and
absence (3) of rotenone are essentially identical to those from
rotenone-inhibited complex I. Conditions: 0.4 mg/mL asolectin, 2.3
µM rotenone, 100 µM NADH, 20 mM Tris-HCl (pH 7.55), 32 °C.
2056 Biochemistry, Vol. 48, No. 9, 2009 King et al.NADH Is Oxidized Superstoichiometrically in the Presence
of Hydrophilic Quinones. The reaction between NADH and
quinone, to form NAD+ and quinol, is a two-electron transfer
with a 1:1 stoichiometry, but under conditions which favor
quinone reduction at the ﬂavin site, the reaction becomes
superstoichiometric (Figure 4). The superstoichiometry of
Q1reductionbycomplexIhasalsobeennotedpreviously(24,41).
Figure 4A shows that 50 µMQ 1 is able to oxidize more
than 50 µM NADH, whether asolectin and rotenone are
present or not. Conditions which favor reaction at the ﬂavin
site increase the superstoichiometry, but those that favor the
hydrophobic Q-site decrease it. Only quinols are formed at
the hydrophobic, physiological Q-site, strongly suggesting
that it is semiquinones formed at the ﬂavin site that are
responsible for the superstoichiometry, and that the quinols
are stable end products. Figure 4B shows that superstoichio-
metric reactions do not occur unless O2 is present. The rates
of NADH oxidation themselves do not depend on the
presence of O2, showing that O2 acts indirectly, “recycling”
the semiquinone to the quinone, to be reduced again. Figure
4C shows that NADH:DQ oxidoreduction is stoichiometric
in both the presence and absence of O2, conﬁrming that the
superstoichiometry is associated only with reactions at the
ﬂavin site, and Figure 4D compares the reactions of Q1, IDE,
and Q0, all of which are superstoichiometric.
ReactiVe Oxygen Species Are Produced by the Reduction
of Quinones at the FlaVin Site. Figure 5A shows that quinone
reduction at the ﬂavin site in complex I leads to H2O2
production. The addition of NADH to complex I produces
low levels of H2O2 when O2 is present (35). When DQ is
added, the rates of H2O2 production do not change, but they
are enhanced signiﬁcantly upon addition of Q1. In the absence
of O2 there is a background reaction between one or more
reduced quinone species and the Amplex Red detection
system which is not sensitive to the addition of catalase, and
which is observed for Q1,Q 0, and IDE (see Table 2). In the
presence of O2, the addition of Q1 produces an approximately
10-fold increase in the rate of H2O2 production, to ∼300
nmol min-1 mg-1. This observation is consistent with the
formation of semiquinones which react with O2 to form
superoxide (and subsequently H2O2) in redox cycling reac-
tions (see Scheme 2) (42). Note that, because the rate of
FIGURE 3: Dependence of the rate of NADH:Q oxidoreduction at the hydrophilic site on NADH and Q concentration. (A) Dependence of
NADH:Q1 oxidoreduction on Q1 concentration in 30 (O) and 100 µM NADH (b). (B) Dependence of NADH:Q1 oxidoreduction on NADH
concentration at 100 (O) and 250 µMQ 1 (b). The data in panels A and B have been ﬁtted using the ping-pong mechanism, using the
parameters in row 4 of Table 1. (C) Dependence of NADH:Q0 oxidoreduction on NADH concentration in 100 (O) and 250 µMQ 0 (b). (D)
Dependence of NADH:IDE oxidoreduction on NADH concentration in 100 (O) and 250 µM IDE (b). The data in panels C and D have
been ﬁtted using the ping-pong-pong mechanism, using the parameters in rows 11 and 12 of Table 1. Conditions: 32 °C in 20 mM Tris-HCl
(pH 7.55) and 2.3 µM rotenone.
Scheme 1: Mechanism of Quinone Reduction at the Flavin
Active Site, Incorporating both the Ping-Pong and
Ping-Pong-Pong Reactions, and Double-Substrate Inhibition
a
a The ping-pong and ping-pong-pong reactions diverge at [FlRed Q]:
the ping-pong reaction follows the dotted arrow to produce QH2 and
returns directly to [FlOx], and the ping-pong-pong reaction follows the
outside pathway to form two semiquinones (QH•). Abbreviations:
FlOx/Red, oxidized or reduced state of the ﬂavin; terms in brackets,
enzyme-bound species; kcat, ﬁrst-order rate constant for substrate
transformation and product dissociation; KM, Michaelis-Menten con-
stant; KOx, KSemi, and KRed, dissociation constants, referring to the
oxidized, semireduced, and reduced enzyme states, respectively.
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reaction of O2 is not with the enzyme or with an enzyme-
bound quinone or semiquinone species, but with the products
of the enzyme-catalyzed reaction.
Figure 5B shows equivalent experiments using acety-
lated cytochrome c (cyt c), an established system for the
detection of superoxide (37). In the absence of a quinone,
the rates of cyt c reduction are low and abolished in the
absence of O2 (35). When DQ is added, they do not change
signiﬁcantly, though a small increase in the absence of
O2 is observed when phospholipids are absent. When Q1
is added, a signiﬁcant increase is observed, both in the
presence and in the absence of O2. In addition to being
reduced by superoxide, cyt c is reduced directly by
semiquinone radicals also, with the interpretation of
experimental data complicated further by equilibria being
established between O2 and semiquinone, and superoxide
and quinone (42). We note that an increase in the level
of superoxide production in the presence of hydrophilic
quinones has been observed previously (24, 25), and that
Table 1: Kinetic Parameters for the Reduction of Q1,Q 0, and IDE at the Hydrophilic, Flavin Site in Complex I, Determined by Fitting Experimental
Data to the Ping-Pong and Ping-Pong-Pong Mechanisms
Ping-Pong Mechanism
KM
NADH (µM) kcat
NADH (s-1) KRed
NADH (µM) KM
Q (µM) kcat
Q (s-1) LSQE/LSQEmin
Q1 94 2700 200 354 56.6 2.9
Q0 94 2700 200 292 15.2 1.2
IDE 94 2700 200 5225 660 1.7
Q1 94 2700 70 200 47.4 1
Q0 94 2700 300 345 16.2 1
IDE 94 2700 3001 3770 450 1
Ping-Pong-Pong Mechanism
KM
NADH (µM) kcat
NADH (s-1) KRed
NADH (µM) KSemi
NADH (µM) KM
SQ (µM) kcat
SQ (s-1) KM2
SQ (µM) kcat2
SQ (s-1) LSQE/LSQEmin
Q1 94 2700 200 200 354 113.2 354 113.2 2.9
Q0 94 2700 200 200 292 30.4 292 30.4 1.2
IDE 94 2700 200 200 5225 1320 5225 1320 1.7
Q1 94 2700 300 70 205 500
a 205 50.3 1
Q0 94 2700 300 70 250 14.2 250 242.5 1
IDE 94 2700 300 70 3880 479 3880 20000
a 1.1
a Value increases indeﬁnitely without signiﬁcantly affecting the LSQE value.
FIGURE 4: NADH is oxidized superstoichiometrically in aerobic
quinone-containing solutions. Complex I was incubated in the
presence of ∼50 µM Q (dotted lines) in varying concentrations of
NADH (from 0 to 200 µM). The NADH concentrations were
measured at 2 min intervals, and the amount of NADH oxidized
was determined by comparing measured and initial NADH con-
centrations. (A) NADH oxidation by 50 µMQ 1 in an aerobic
solution in the presence or absence of rotenone (Rot.) and/or
asolectin (Aso.). NADH is oxidized superstoichiometrically. (B)
An experiment equivalent to that conducted for panel A but in an
anaerobic solution (the symbols are conserved). NADH is not
oxidized superstoichiometrically. (C) NADH oxidation by 50 µM
DQ in the presence of asolectin, in anaerobic (O) and aerobic (b)
solutions. NADH is not oxidized superstoichiometrically. (D)
NADH oxidation by 50 µMQ 1, IDE, and Q0 in an aerobic solution
in the presence of rotenone and asolectin. NADH is oxidized
superstoichiometrically. Conditions: 20 mM Tris-HCl, pH 7.55, 32
°C, 2.3 µM rotenone, 0.4 mg/mL asolectin.
FIGURE 5: Effects of DQ, Q1, and O2 on resoruﬁn formation and
cyt c reduction, catalyzed by complex I. (A) Assay traces showing
resoruﬁn formation under aerobic and anaerobic conditions. The
assays began in a solution containing complex I; NADH was added
after 30 s (to reveal a clear distinction between the anaerobic and
aerobic experiments), and then either DQ or Q1 was added. The
addition of DQ did not affect the rate of resoruﬁn formation, but
the addition of Q1 caused it to increase, especially in the presence
of O2. (B) Assay traces showing cyt c reduction under aerobic and
anaerobic conditions. The assays began in a solution containing
complex I; NADH was added after 30 s (again revealing a clear
distinction between the anaerobic and aerobic experiments), and
then either DQ or Q1 was added. In both cases, the addition of Q1
caused signiﬁcant increases in the observed rate. Conditions: 20
mM Tris-HCl, pH 7.55, 32 °C, 30 µM NADH, 100 µMQ ,+O2 )
atmospheric O2, -O2 ) anaerobic glovebox, 2.3 µM rotenone, 50
µM cyt c, 2 units/mL HRP, 10 µM Amplex Red.
2058 Biochemistry, Vol. 48, No. 9, 2009 King et al.hydrophilic quinones have been suggested to mediate O2
reduction by the ﬂavin in complex I also (43).
Table 2 presents a comprehensive summary of data from
the Amplex Red and cyt c detection systems for each of the
four Q species. DQ exhibits the slowest rates of reaction,
dominated by the direct reaction of the reduced ﬂavin with
O2 (35), and enhanced slightly by semiquinone formation
only in the absence of asolectin. For Q1, both the Amplex
Red and cyt c detection systems are consistent with
signiﬁcant semiquinone formation, and with interconversions
between semiquinone and O2, and superoxide and quinone.
As expected, one-electron cyt c reduction (in the absence of
asolectin and in the presence of rotenone) is close to twice
as fast as two-electron H2O2 formation, and cyt c reduction
is not abolished by SOD. We note that the level of H2O2
formation by Q1 in the presence of rotenone and asolectin
together is ∼20% lower than in the presence of either
rotenone or asolectin alone. This observation is difﬁcult to
explain, but it may be because either asolectin or the steady-
state level of reduced ﬂavin affects the ratio of quinol to
semiquinone formation at the ﬂavin site, and their stability
and reactivity in solution also. The rates of H2O2 production
by IDE are comparable to those of Q1, but they are
signiﬁcantly enhanced in the absence of asolectin, consistent
with the increase in the rate of the hydrophilic reaction
observed under the same conditions (see Figure 1). Q0 (and
IDE, to a lesser extent) causes signiﬁcantly more cyt c
reduction than H2O2 formation. It is possible that the
hydrophilic Q0 semiquinone is more stable in aqueous
solution, so that superoxide formation is less favored or the
semiquinone dismutates directly. Scheme 2 summarizes the
reaction pathways which originate at the ﬂavin site in
complex I.
DISCUSSION
Identiﬁcation of the FlaVin Site as the Hydrophilic
Q-Binding Site. Two pieces of evidence strongly suggest that
the hydrophilic site of quinone reduction in complex I is the
ﬂavin site at which NADH is oxidized: the hydrophilic
reaction is conserved in a preparation of subcomplex Iλ
which lacks the terminal iron-sulfur cluster N2 and the
hydrophobic Q-binding site, and it is inhibited by high
NADH concentrations and can be explained mechanistically
using ping-pong or ping-pong-pong kinetics (using param-
eters derived from the study of transhydrogenation reactions
at the ﬂavin). Previously, the hydrophilic site of quinone
reduction in complex I has been attributed to essentially every
conceivable reaction site (see above), but until now, no
investigation has aimed speciﬁcally at identifying the site
or presented substantial experimental support for any proposal.
Ping-pong reactions involving NADH and quinones at
ﬂavins are well-known in the diverse class of single-subunit
NADH:Q oxidoreductases. Kinetic evidence of a ping-pong
mechanism in one of the alternative (non-energy transducing)
NADH dehydrogenases which react with extremely hydro-
phobic quinones such as Q10, and which replace complex I
in the respiratory chains of a number of species, has been
presented (44). However, related enzymes which are involved
in detoxiﬁcation have been studied more extensively. In
contrast to complex I, which has a thermodynamically
accessible ﬂavosemiquinone (45), they are obligatory two-
electron donors (perhaps because they reduce bound quinones
by the transfer of hydride from the ﬂavin), and so they avoid
the formation of semiquinone species and redox cycling
reactions (46). The structure of duroquinone bound to human
NAD(P)H:quinone oxidoreductase shows the quinone ring
stacked above the ﬂavin isoalloxazine system (47), providing
a visual representation for how quinones may bind and react
at the ﬂavin site in complex I.
Table 2: Resoruﬁn Formation (H2O2 formation) and cyt c Reduction (O2
•- formation) in the Presence of Hydrophilic Quinones Depend on the Presence
of Asolectin, Rotenone, and O2
a
Resoruﬁn Formation (nmol min-1 mg-1)
Aso Rot O2 CAT DQ Q1 Q0 IDE
+- +-33.9 ( 0.1 303.8 ( 21.0 29.7 ( 3.2 119.7 ( 1.3
++ +-29.4 ( 6.6 234.6 ( 1.2 26.2 ( 0.8 123.0 ( 0.3
-- +-40.9 ( 4.6 307.7 ( 4.4 38.0 ( 2.5 246.6 ( 11.4
-+ +-41.5 ( 2.0 300.1 ( 32.8 38.5 ( 5.7 257.8 ( 12.9
-+ ++ 3.6 ( 0.3 23.0 ( 1.2 16.0 ( 0.7 23.5 ( 2.3
-+ -- 1.0 ( 0.4 24.9 ( 1.6 9.6 ( 0.8 25.4 ( 3.6
Cyt c Reduction (nmol min-1 mg-1)
Aso Rot O2 SOD DQ Q1 Q0 IDE
-+ +-48.4 ( 3.3 532.0 ( 32.6 276.8 ( 5.0 432.7 ( 3.0
-+ ++ 6.4 ( 2.5 203.4 ( 6.8 125.7 ( 2.5 208.6 ( 18.3
-+ --26.2 ( 3.0 609.0 ( 14.6 315.3 ( 4.7 461.6 ( 9.5
-+ -+24.3 ( 0.9 552.4 ( 5.2 263.1 ( 1.9 419.5 ( 23.2
a Conditions: 20 mM Tris-HCl, pH 7.55, 32 °C, 30 µM NADH, 100 µMQ ,+O2 ) atmospheric O2, -O2 ) anaerobic glovebox, Aso ) 0.4 mg/mL
asolectin, Rot ) 2.3 µM rotenone, or 10 µM rotenone for IDE, CAT ) 10000 units/mL catalase, SOD ) 50 units/mL Cu-Zn-SOD, 50 µM cyt c, 2
units/mL HRP, 10 µM Amplex Red.
Scheme 2: Production, Interconversion, and Detection of the
Reactive Oxygen and Semiquinone Species Produced by the
Reduced Flavin in Complex I
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Hydrophobic and Hydrophilic Sites in Isolated Complex I?
Phospholipids may affect the reactivity of isolated complex
I toward a short-chain ubiquinone in two ways: they may
bind to the enzyme, at the active site or as a phospholipid
annulus, to stabilize active conformations and promote
catalytic activity (the “enzyme effect”), or they may alter
the availability of the quinone to the enzyme, by partitioning
it into a hydrophobic phase or by dispersing quinone micelles
(the “quinone effect”).
The reaction at the hydrophobic site is enhanced strongly
by phospholipids in the assay medium (Figure 1, also
observed in many previous studies, for example, refs 7, 28,
and 48-50), an effect that is not mimicked by similar
concentrations of detergents, suggesting the importance of
the enzyme effect. However, previous studies have suggested
that the quinone effect contributes also. In studies of SMPs
(for which the enzyme effect does not apply), detergents or
sonicated phospholipids were found to enhance the rate of
DQ reduction by complex I, probably by dispersing quinone
micelles and aiding quinone-quinol exchange between the
membrane and the aqueous phase (9). An earlier study of
the effects of phospholipid concentration on Q1 reduction
by isolated complex I focused on partitioning of quinone
between the aqueous and lipidic phases. However, the rate
of the hydrophobic reaction did not follow the concentration
of Q1 in the lipidic phase (it followed the total concentration),
and it was increased strongly in higher phospholipid con-
centrations (as observed here) (7). Indeed, if partitioning is
the dominant effect, then higher phospholipid concentrations
should actually decrease the rate of the hydrophobic reaction,
by increasing the volume of the hydrophobic phase and
diluting the Q1. We conclude that, in studies of the isolated
enzyme, the enzyme effect is dominant in controlling the
reaction at the hydrophobic site, although (particularly with
the more hydrophobic quinones) the quinone effect may also
contribute.
It is unlikely that there is a signiﬁcant enzyme effect at
the hydrophilic binding site, and Figure 1 shows that the
rate of the hydrophilic reaction tends to decrease with the
addition of phospholipids. The effect is most marked for IDE,
observed to a lesser extent for Q1 and not at all for Q0 (for
DQ the hydrophilic reaction site is so slow that no conclu-
sions can be drawn). Previously, for isolated complex I and
Q1, Ragan proposed that phospholipids partition the Q1 out
of the hydrophilic phase, so that it cannot interact with the
hydrophilic site (7). The extent of hydrophilic Q1 reduction
was decreased by ∼45% in 0.4 mg/mL phospholipids
[compared to ∼20% observed here (Figure 1)]; however, the
phospholipid dependence was investigated in much greater
depth than we have attempted, and a convincing ﬁt, over a
range of phospholipid and Q1 concentrations, was described.
The fact that IDE reduction at the hydrophilic site is most
affected by phospholipids, and Q0 reduction least affected,
is consistent with the relative partition coefﬁcients of IDE,
Q1, and Q0. However, note that the extent of partitioning
may differ when biological membranes are present and that
neither partition coefﬁcients or the concept of a hydrophobic
phase is physically relevant to experiments on isolated
complex I. Instead, the system comprises mixed micelles of
quinone, phospholipid, and detergent (plus a large hydro-
phobic enzyme). Equations for describing mixed micelle
formation are available (51, 52), but the complexity of our
system and the lack of basic information about the micellular
properties of its components allow them to provide only
general physical insights at present.
The Identity of the Ubiquinone Determines Its Rate of
Reaction at both the Hydrophobic and Hydrophilic Sites. The
relative rates of reaction of the four ubiquinones at the
hydrophobic and hydrophilic sites do not correlate in a simple
fashion with their hydrophobicity. At the ﬂavin site, the
ubiquinone ring probably stacks against the ﬂavin isoallox-
azine ring system, with the hydrophobic tail lying along the
channel which binds the ADP-ribose moiety of NADH. The
release of bound waters upon binding will tend to increase
the afﬁnity as the hydrophobic tail lengthens, explaining the
low rate of reaction of Q0. For the more hydrophobic
quinones, such as DQ, the entropic effect is opposed by their
decreasing solubility in the external solution, so the maximal
activity is observed for Q1 and IDE. It is possible that the
binding of IDE is enhanced by hydrogen bonding between
its terminal hydroxyl group and a nearby charged residue in
the site. For the hydrophobic site, Sakamoto and co-workers
studied the reduction of a range of coenzyme Q2 derivatives
by complex I (53). They concluded that the role of the tail
is not simply to enhance the hydrophobicity and attributed
the high afﬁnity of Q2 itself to molecular interactions between
the binding site and the methyl branch and π-system of the
ﬁrst isoprene unit. The fact that Q2 reacts more slowly than
DQ, for example, was attributed to slow dissociation of the
ubiquinol product. The characteristics of reduction of Q2 and
IDE by complex I are similar (24), and our results are
consistent with IDE reduction being limited by product
dissociation also. Thus, reactivity at the hydrophobic site
requires an “intermediate afﬁnity”, high enough for binding
and reaction but not high enough to cause inhibition. DQ
and Q1 react rapidly because they have intermediate afﬁnities;
IDE reacts slowly because it has an overly high afﬁnity, and
Q0 probably reacts slowly because it has an overly low
afﬁnity. Importantly, the afﬁnities are again affected by how
the quinone interacts with the external environment, and this
may differ considerably between a membrane and a micellar
system.
Here, we suggest that DQ is the most appropriate substrate
for complex I, in systems which lack endogenous quinone.
Under appropriate conditions, it displays a substantial rate
at the hydrophobic (physiological) quinone binding site and
a minimal rate at the ﬂavin site. For some experiments, in
which the effects of the reaction at the ﬂavin site can be
subtracted out, Q1 also displays a substantial rate at the
hydrophobic site. However, Q1 is clearly very unsuitable for
any investigation of reactive oxygen species generation or
semiquinone formation by complex I.
Implications for Complex I in Mitochondria. IDE has
shown some promise in counteracting the cardiomyopathy
associated with Friedreich’s Ataxia, a neurodegenerative
disease (27). Although IDE undoubtedly reacts in several
different ways in mitochondria (24, 32), we are concerned
here with only complex I. IDE is reduced by the ﬂavin in
complex I, to produce semiquinone species which result in
an increased level of reactive oxygen species formation, and
it is reduced slowly at the physiological quinone binding site.
The rates of both reactions are affected by how IDE partitions
between the membrane and the aqueous phases. The “nega-
2060 Biochemistry, Vol. 48, No. 9, 2009 King et al.tive” effects of IDE are thus reactive oxygen species
production, and the inhibition of physiological quinone
reduction, caused by slow IDE product release. The “posi-
tive” effects of IDE are that, if Q10 is not sufﬁciently
available, it increases the rate of NADH oxidation and
regenerates NAD+, and its high afﬁnity means that it may
be more effective at outcompeting an inhibitor or reacting
with a damaged binding site.
It is clear that the extremely hydrophobic, physiological
quinone cannot react at the ﬂavin site in complex I, because
the site is spatially separated from the membrane and must
be entered from the aqueous phase (Q10 is unable to
dissociate from the membrane); the ﬂavin-mediated reaction
is only relevant for relatively hydrophilic quinones. However,
the ability of the ﬂavin site to reduce quinones at all suggests
that it is more promiscuous than previously considered: it
may be capable of binding and reacting with many different
compounds. Indeed, a number of compounds which are used,
for example, as drugs or pesticides have been reported to
undergo redox cycling reactions at complex I. Important
examples are anthracyclines such as adriamycin (a chemo-
therapeutic agent with cardiotoxic side effects) (54) and
paraquat (a herbicide, which is used to increase the level of
superoxide production in biochemical studies of oxidative
stress also) (55). Furthermore, in Parkinson’s disease, there
is considerable evidence of oxidative damage to dopamin-
ergic neurons, and of the involvement of complex I (56). It
is possible that quinoid compounds, from the environment
or produced as metabolic byproducts or in the metabolism
of dopamine, contribute to the production of reactive oxygen
species by reacting by the mechanism described. Thus, the
role of the complex I ﬂavin site in promoting redox cycling
reactions and reactive oxygen species production, mediated
by a variety of compounds and via a universal reaction
mechanism, is worthy of further consideration.
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